Mobilization of pre-existing polyclonal T cells specific to neoantigens but not self-antigens during treatment of a patient with melanoma with bempegaldesleukin and nivolumab

T cells that recognize self-antigens and mutated neoantigens are thought to mediate antitumor activity of immune checkpoint blockade (ICB) in melanoma. Few studies have analyzed self and neoantigen-specific T cell responses in patients responding to ICB. Here, we report a patient with metastatic mel...

Descripción completa

Detalles Bibliográficos
Autores principales: Veatch, Joshua R, Singhi, Naina, Jesernig, Brenda, Paulson, Kelly G, Zalevsky, Jonathan, Iacucci, Ernesto, Tykodi, Scott S, Riddell, Stanley R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Clinical/Translational Cancer Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733177/
https://www.ncbi.nlm.nih.gov/pubmed/33298619
http://dx.doi.org/10.1136/jitc-2020-001591

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733177/
https://www.ncbi.nlm.nih.gov/pubmed/33298619
http://dx.doi.org/10.1136/jitc-2020-001591

Ejemplares similares